NR3C2 and nonpapillary renal cell carcinoma: Finally, we constructed a new immune-related ceRNA network successfully, in which low-expressed NNT-AS1 downregulated NR3C2 and VAV3 to promote ccRCC through upregulating hsa-miR-186-5p.